XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Note 2 - Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   Three Months Ended September 30,       Nine Months Ended September 30,     
 

2025

  

 2024

  

2025

  

2024

 

Numerator:

                

Net income (loss)

 $(2,615,163) $(3,459,754) $3,164,500  $(12,705,049)

Accrued dividends on Series F Preferred Stock

  (36,112)  (47,879)  (155,800)  (158,862)

Deemed dividends

  (208,526)  (1,450,232)  (4,942,669)  (6,707,687)

Numerator for basic EPS - net income (loss) available to common stockholders

  (2,859,801)  (4,957,865)  (1,933,969)  (19,571,598)
                 

Effect of convertible securities and liability classified equity instrument:

                

Accrued dividends on Series F Preferred Stock

        155,800    

Interest expense on convertible note payable

        45,150    

Gain on change in fair value of warrant liabilities

        (8,511,000)   

Numerator for diluted EPS - net loss available to common stockholders

 $(2,859,801) $(4,957,865) $(10,244,019) $(19,571,598)
             

Denominator:

                

Denominator for basic EPS - weighted average shares

  32,171,261   309,350   19,888,046   240,309 
                 

Effect of dilutive securities:

                

Incremental shares for outstanding warrants

            

Convertible Series F Preferred Stock

        2,143,977    

Series A Warrants outstanding alternate cashless exercise

        60,973    

Unvested restricted stock units

        106,797    

Denominator for diluted EPS - weighted average shares

  32,171,261   309,350   22,199,793   240,309 
                 

Net loss per common share - basic

 $(0.09) $(16.03) $(0.10) $(81.44)
                 

Net loss per common share - diluted

 $(0.09) $(16.03) $(0.46) $(81.44)